PSN Labs responds to Philips lawsuit
By HME News Staff
Updated 10:33 AM CDT, Mon October 7, 2024
PITTSBURGH – PSN Labs has disputed claims made by Philips that the lab caused “significant damage” to the company by conducting “numerous egregious errors in its testing and analysis” related to recalled sleep and respiratory devices. In a response filed Sept. 27 in the U.S. District Court for the Western District of Pennsylvania, PSN says the company “has continued to mischaracterize testing results in an effort to conceal the ultimate foam degradation issue.” “Philips, similar to its attempts against other third parties, is attempting to deflect attention to PSN Labs and away from Philips’ own failures, negligence, concealment and recklessness,” it stated. Philips, in a lawsuit filed July 29, says PSN’s work was a big reason it initiated a worldwide recall of more than 15 million sleep and respiratory devices in June 2021 and that the company would have pursued a “different and more focused recall” had PSN not “overestimated the potential threats to patients.” In its 48-page response, PSN points out that Philips did not engage the lab until 2021, well after the company began researching the foam degradation issue in 2016. “PSN Labs’ one report is not the reason or the basis for the Philips recall,” the response stated. PSN has called for a jury trial.
Comments